Influence of cytoskeleton organization on recombinant protein expression by CHO cells.

Détails

Ressource 1Télécharger: 31956990_BIB_02A3B3842F19.pdf (1708.90 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_02A3B3842F19
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Influence of cytoskeleton organization on recombinant protein expression by CHO cells.
Périodique
Biotechnology and bioengineering
Auteur⸱e⸱s
Pourcel L., Buron F., Arib G., Le Fourn V., Regamey A., Bodenmann I., Girod P.A., Mermod N.
ISSN
1097-0290 (Electronic)
ISSN-L
0006-3592
Statut éditorial
Publié
Date de publication
04/2020
Peer-reviewed
Oui
Volume
117
Numéro
4
Pages
1117-1126
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
In this study, we assessed the importance of cytoskeleton organization in the mammalian cells used to produce therapeutic proteins. Two cytoskeletal genes, Actin alpha cardiac muscle 1 (ACTC1) and a guanosine triphosphate GTPase-activating protein (TAGAP), were found to be upregulated in highly productive therapeutic protein-expressing Chinese hamster ovary (CHO) cells selected by the deprivation of vitamin B5. We report here that the overexpression of the ACTC1 protein was able to improve significantly recombinant therapeutic production, as well as to decrease the levels of toxic lactate metabolic by-products. ACTC1 overexpression was accompanied by altered as well as decreased polymerized actin, which was associated with high protein production by CHO cell cultured in suspension. We suggest that the depolymerization of actin and the possible modulation of integrin signaling, as well as changes in basal metabolism, may be driving the increase of protein secretion by CHO cells.
Mots-clé
CHO cells, actin polymerization, cytoskeleton regulation, recombinant protein production
Pubmed
Web of science
Open Access
Oui
Création de la notice
23/01/2020 14:15
Dernière modification de la notice
30/04/2021 7:08
Données d'usage